Check out this outstanding PhD opportunity for pharmacy graduates to work with @ChiaraDeSanti3@cristinareschke and myself in @RCSI_Irl. An amazing chance to learn from researchers (#iPSC), clinicians and patients with pulmonary fibrosis. Link below @ILFA_Ireland @irishthoracicS
"I don't know how I'd go back to the HSE – and kind of be treated like dirt, essentially."
Why are junior doctors leaving Ireland for Australia? Irish hospitals could face staff shortages, explains @ConorWilson | #rtept | #doctors | Read more: https://t.co/bEYQXNapx9
Congratulations to @ToaleConor on his hot-off-the-press systematic review in @SurgJournal on the use of operative experience thresholds to determine trainee competence https://t.co/fLDgPfULcz Dr Toale's research is supported by the RCSI StAR MD programme & @hermitageclinic
Experts in non-cystic fibrosis bronchiectasis, Dr Charles Daley, Prof. Stefano Aliberti & Dr Anne O’Donnell, share their insights on current & future best practice for optimizing the management of patients with non-cystic fibrosis bronchiectasis.
Watch: https://t.co/GAlFVDmWD6
Over 70,000 people are living with #CysticFibrosis (CF) globally and Ireland has the highest incidence in the world.
New research from Prof Emer Reeves reveals an additional benefit of an existing drug treatment for people with CF: https://t.co/vJ9tcM6Nbn
#RCSIdiscover
Over 70,000 people are living with #CysticFibrosis (CF) globally and Ireland has the highest incidence in the world.
New research from Prof Emer Reeves reveals an additional benefit of an existing drug treatment for people with CF: https://t.co/vJ9tcM6Nbn
#RCSIdiscover
Thrilled to see our review on the effect of effective #CFTR modulation on interleukin-8 in cystic fibrosis published in Expert Review of Respiratory Medicine 🥳🤩 @RCSI_RespLab @RCSI_Irl @RCSI_Research https://t.co/3viloyi44s
Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy https://t.co/hX3ifY3wi7 TA: @MSUPedsPulm